Isagen SA ESP:発電所・企業SWOT分析

◆英語タイトル:Isagen SA ESP - Power Plants and SWOT Analysis, 2017 Update
◆商品コード:DATA8012328
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月8日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:グローバル
◆産業分野:発電・エネルギー
◆販売価格オプション(消費税別)
Single UserUSD1,000 ⇒換算¥148,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD2,000 ⇒換算¥296,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD3,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Isagen SA ESP – Power Plants and SWOT Analysis, 2017 Update
Summary

The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services.

Scope

- Major Power Plants (assets) – summarized and detailed information about the power plants (assets).
- Operational Metrics (capacity, generation, revenue, sales, number of consumers).
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands
- Key employees – A list of the key executives and personnel heading key departments/functions.
- Executive biographies – A brief summary of the executives’ employment history.
- Financial deals – Coverage of key financial deals from 2006 onwards, depending upon information availability
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

* Note: Some sections may be missing if data is unavailable for the company.

Reasons to buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis, corporate strategy and major products and services are incorporated in the profile to assist in various business decisions (M&A and JV).
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing an up to date objective view of the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
Company Snapshot 4
Key Information 4
Company Overview 4
SWOT Snapshot 4
Operational Metrics 5
Isagen SA ESP, Operational Metrics, By Capacity 5
Isagen SA ESP, Operational Metrics, By Generation 5
Isagen SA ESP, Operational Metrics, By Segmental Information 5
Isagen SA ESP, Operational Metrics, By Sales 5
Isagen SA ESP, Wind Farms 6
Isagen SA ESP, Wind Farms, Colombia 6
Isagen SA ESP, Hydro Power Plants 7
Isagen SA ESP, Hydro Power Plants, Colombia 7
Isagen SA ESP, Thermal Power Plants 8
Isagen SA ESP, Thermal Power Plants, Colombia 8
Business Description 9
Business Overview 9
Major Products and Services 10
History 11
SWOT Analysis 13
Overview 13
Isagen SA ESP Strengths 13
Market Position 13
Operational Capabilities 13
Working Capital Surplus 13
Isagen SA ESP Weaknesses 14
Operational Performance 14
Isagen SA ESP Opportunities 14
Renewable Energy Initiatives 14
Increase in Demand for Electricity 14
Palagua Hydroelectric Power Plant Project 14
Isagen SA ESP Threats 14
Regulations 14
Operational Issues 14
El Nino Southern Oscillation Phenomenon 14
Key Employees 16
Key Employee Biographies 17
Company Statement 18
Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Financial Deals Landscape 20
Isagen SA ESP, Deals Summary 20
Isagen SA ESP, Power, Deal Details 21
Asset Transactions 21
ISAGEN Completes Project Financing of USD1.13 Billion for Hidrosogamoso Hydroelectric Power Plant in Colombia 21
Acquisition 22
Brookfield Renewable Partners Acquires Additional 25.4% Stake in Isagen for USD965.9 Million 22
Brookfield Renewable Energy Partners Complete Acquisition of 57.6% Stake in Isagen from Colombia for USD2.2 Billion 23
Appendix 25
Report Scope 25
GlobalData Coverage 25
Benchmarking 25
GlobalData’s Methodology 25
Secondary Research 25
Primary Research 26
Contact Us 26
Disclaimer 26

List of Tables
Isagen SA ESP, Key Facts 4
Isagen SA ESP, Operational Metrics, Capacity 5
Isagen SA ESP, Operational Metrics, Generation 5
Isagen SA ESP, Operational Metrics, Segmental Information 5
Isagen SA ESP, Operational Metrics, Sales 5
Isagen SA ESP, Wind Farms, Colombia 6
Isagen SA ESP, Hydro Power Plants, Colombia 7
Isagen SA ESP, Thermal Power Plants, Colombia 8
Major Products and Services 10
Isagen SA ESP, SWOT Analysis 13
Isagen SA ESP, Key Employees 16
Isagen SA ESP, Other Locations 19
Isagen SA ESP, Deals Summary 20
ISAGEN Completes Project Financing of USD1.13 Billion for Hidrosogamoso Hydroelectric Power Plant in Colombia 21
Brookfield Renewable Partners Acquires Additional 25.4% Stake in Isagen for USD965.9 Million 22
Brookfield Renewable Energy Partners Complete Acquisition of 57.6% Stake in Isagen from Colombia for USD2.2 Billion 23

★海外企業調査レポート[Isagen SA ESP:発電所・企業SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Exalenz Bioscience Ltd (EXEN):医療機器:M&Aディール及び事業提携情報
    Summary Exalenz Bioscience Ltd (Exalenz) carries out the development and commercialization of advanced medical systems for a range of gastrointestinal (GI) tract and liver disorders. The company harnesses its BreathID technology platform for assessment and monitoring of functional diseases. Its flag …
  • Progenity Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Progenity, Inc. (Progenity) is a US based company engaged in providing specialized diagnostic and complex molecular tests to clinicians. The company offers molecular and diagnostic testing for inheritable cancer, pre-eclampsia and genetic disorders to children and women. It also provides ser …
  • Coca-Cola Amatil Limited:戦略・SWOT・企業財務分析
    Coca-Cola Amatil Limited - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola Amatil Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Kolon Industries Inc (120110):企業の財務・戦略的SWOT分析
    Kolon Industries Inc (120110) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • RRB Energy Ltd:企業の戦略的SWOT分析
    RRB Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • UCB SA (UCB):医療機器:M&Aディール及び事業提携情報
    Summary UCB SA (UCB) is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the treatment of central nervous system (CNS) and immunology related conditions. The company's key medicines …
  • Insmed Inc (INSM)-医療機器分野:企業M&A・提携分析
    Summary Insmed Inc (Insmed) is a biopharmaceutical company that focuses on rare diseases. Its lead product candidate, Arikayce (liposomal amikacin for inhalation), is indicated for the treatment of nontuberculous mycobacteria (NTM) lung disease in adult patients. Its other clinical pipeline includes …
  • Credicorp Ltd (BAP):企業の財務・戦略的SWOT分析
    Credicorp Ltd (BAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Tulip Diagnostics (P) Ltd-医療機器分野:企業M&A・提携分析
    Summary Tulip Diagnostics (P) Ltd (Tulip Diagnostics), a subsidiary of Tulip Group is a diagnostic company that manufactures and markets in vitro diagnostic reagents and kits for the medical markets. The company provides assay systems for immunohaematology, hematology, rheumatology, infectious disea …
  • Devon Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Devon Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Devon Energy Corp (Devon Energy) is an independent energy company. The company carries out exploration, development, and production of oil, natural gas and natural gas liquids (NGLs). It has its op …
  • 21st Century Oncology Inc:企業の戦略的SWOT分析
    21st Century Oncology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • WInco Foods LLC:企業の戦略・SWOT・財務情報
    WInco Foods LLC - Strategy, SWOT and Corporate Finance Report Summary WInco Foods LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Bank of Montreal:企業のM&A・事業提携・投資動向
    Bank of Montreal - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bank of Montreal Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Crocs Inc (CROX):企業の財務・戦略的SWOT分析
    Crocs Inc (CROX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • PT Dian Swastatika Sentosa Tbk (DSSA):企業の財務・戦略的SWOT分析
    PT Dian Swastatika Sentosa Tbk (DSSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Institut Gustave Roussy-製薬・医療分野:企業M&A・提携分析
    Summary Institut Gustave Roussy (IGR) is a cancer research institute that offers healthcare services to patients suffering from cancer and conducts research to identify new therapies. The institute provides treatment for the diseases that include endocrine tumours, childhood cancer, gynecological ca …
  • Perma-Fix Environmental Services, Inc. (PESI):企業の財務・戦略的SWOT分析
    Perma-Fix Environmental Services, Inc. (PESI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Telekom Malaysia Berhad:企業の戦略・SWOT・財務分析
    Telekom Malaysia Berhad - Strategy, SWOT and Corporate Finance Report Summary Telekom Malaysia Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Maerki Baumann & Co. AG:企業の戦略・SWOT・財務情報
    Maerki Baumann & Co. AG - Strategy, SWOT and Corporate Finance Report Summary Maerki Baumann & Co. AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Evoke Pharma Inc (EVOK):製薬・医療:M&Aディール及び事業提携情報
    Summary Evoke Pharma Inc (Evoke Pharma) is a pharmaceutical company that develops drugs to treat gastrointestinal diseases. The company offers Gimoti that provides predictable absorption and symptom relief during a flare regardless of gastric emptying delays and vomiting. It also offers solutions fo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆